Vigilant Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-173
Closed -$31K 513
2022
Q3
$31K Buy
173
+90
+108% +$17.8K ﹤0.01% 336
2022
Q2
$17K Sell
83
-157
-65% -$33.3K ﹤0.01% 381
2022
Q1
$57K Buy
240
+225
+1,500% +$52.8K ﹤0.01% 275
2021
Q4
$3K Sell
15
-14
-48% -$3.08K ﹤0.01% 606
2021
Q3
$6K Buy
29
+14
+93% +$2.84K ﹤0.01% 606
2021
Q2
$3K Hold
15
﹤0.01% 408
2021
Q1
$3K Sell
15
-200
-93% -$39.4K ﹤0.01% 348
2020
Q4
$39K Buy
215
+15
+8% +$2.55K ﹤0.01% 243
2020
Q3
$33K Hold
200
﹤0.01% 250
2020
Q2
$33K Sell
200
-140
-41% -$25.1K ﹤0.01% 231
2020
Q1
$59K Sell
340
-560
-62% -$111K 0.01% 188
2019
Q4
$181K Buy
900
+105
+13% +$21.5K 0.02% 148
2019
Q3
$168K Buy
795
+495
+165% +$103K 0.02% 149
2019
Q2
$58K Hold
300
0.01% 228
2019
Q1
$49K Hold
300
0.01% 246
2018
Q4
$56K Sell
300
-75
-20% -$13.8K 0.01% 243
2018
Q3
$64K Hold
375
0.01% 249
2018
Q2
$61K Sell
375
-52
-12% -$8.49K 0.01% 235
2018
Q1
$69K Buy
427
+375
+721% +$59.7K 0.01% 198
2017
Q4
$8K Buy
+52
New +$7.41K ﹤0.01% 352

Other funds holding CME

Vigilant Capital Management's CME Position: Q4 2022 in Review

Vigilant Capital Management sold out of CME Group (CME) in Q4 2022, closing a stake of 173 shares — an estimated $31K sold.

Vigilant Capital Management first reported a position in CME in Q4 2017 and held it in 20 quarters. The position peaked at $181K in Q4 2019. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

  • Vigilant Capital Management reported no remaining CME Group position as of Q4 2022 after selling out during the quarter.
  • Vigilant Capital Management sold 173 CME Group shares in Q4 2022, an estimated $31K.
  • Vigilant Capital Management first reported a position in CME Group in Q4 2017 and held it in 20 quarters.
  • Vigilant Capital Management's CME Group position peaked at $181K in Q4 2019.
  • 1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on Vigilant Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.